清晨好,您是今天最早来到科研通的研友!由于当前在线用户较少,发布求助请尽量完整地填写文献信息,科研通机器人24小时在线,伴您科研之路漫漫前行!

Clopidogrel with or without Omeprazole in Coronary Artery Disease

医学 奥美拉唑 氯吡格雷 内科学 危险系数 安慰剂 阿司匹林 心肌梗塞 胃肠道出血 临床终点 冲程(发动机) 胃肠病学 随机对照试验 外科 置信区间 替代医学 病理 工程类 机械工程
作者
Deepak L. Bhatt,Byron Cryer,Charles F. Contant,Marc C. Cohen,Angel Lanas,Thomas J. Schnitzer,Thomas Shook,Pablo Lapuerta,Mark A. Goldsmith,Loren Laine,Benjamin M. Scirica,Sabina A. Murphy,Christopher Paul Cannon
出处
期刊:The New England Journal of Medicine [Massachusetts Medical Society]
卷期号:363 (20): 1909-1917 被引量:1319
标识
DOI:10.1056/nejmoa1007964
摘要

BACKGROUND: Gastrointestinal complications are an important problem of antithrombotic therapy. Proton-pump inhibitors (PPIs) are believed to decrease the risk of such complications, though no randomized trial has proved this in patients receiving dual antiplatelet therapy. Recently, concerns have been raised about the potential for PPIs to blunt the efficacy of clopidogrel. METHODS: We randomly assigned patients with an indication for dual antiplatelet therapy to receive clopidogrel in combination with either omeprazole or placebo, in addition to aspirin. The primary gastrointestinal end point was a composite of overt or occult bleeding, symptomatic gastroduodenal ulcers or erosions, obstruction, or perforation. The primary cardiovascular end point was a composite of death from cardiovascular causes, nonfatal myocardial infarction, revascularization, or stroke. The trial was terminated prematurely when the sponsor lost financing. RESULTS: We planned to enroll about 5000 patients; a total of 3873 were randomly assigned and 3761 were included in analyses. In all, 51 patients had a gastrointestinal event; the event rate was 1.1% with omeprazole and 2.9% with placebo at 180 days (hazard ratio with omeprazole, 0.34, 95% confidence interval [CI], 0.18 to 0.63; P<0.001). The rate of overt upper gastrointestinal bleeding was also reduced with omeprazole as compared with placebo (hazard ratio, 0.13; 95% CI, 0.03 to 0.56; P = 0.001). A total of 109 patients had a cardiovascular event, with event rates of 4.9% with omeprazole and 5.7% with placebo (hazard ratio with omeprazole, 0.99; 95% CI, 0.68 to 1.44; P = 0.96); high-risk subgroups did not show significant heterogeneity. The two groups did not differ significantly in the rate of serious adverse events, though the risk of diarrhea was increased with omeprazole. CONCLUSIONS: Among patients receiving aspirin and clopidogrel, prophylactic use of a PPI reduced the rate of upper gastrointestinal bleeding. There was no apparent cardiovascular interaction between clopidogrel and omeprazole, but our results do not rule out a clinically meaningful difference in cardiovascular events due to use of a PPI. (Funded by Cogentus Pharmaceuticals; ClinicalTrials.gov number, NCT00557921.).
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
不以发布了新的文献求助10
7秒前
温柔的海秋完成签到,获得积分10
11秒前
不以完成签到,获得积分10
18秒前
28秒前
44秒前
顺利的雅旋完成签到,获得积分10
47秒前
充电宝的应助被科研通管家采纳,获得10
49秒前
顾矜的应助被科研通管家采纳,获得10
49秒前
爆米花的应助被科研通管家采纳,获得10
50秒前
cczzhh发布了新的文献求助10
51秒前
房天川完成签到 ,获得积分10
1分钟前
qq完成签到 ,获得积分0
1分钟前
eagletyr完成签到 ,获得积分10
1分钟前
成就云朵完成签到,获得积分10
1分钟前
小二郎的应助被钟茵沐采纳,获得10
2分钟前
欣慰怀梦完成签到,获得积分10
2分钟前
2分钟前
小野发布了新的文献求助10
2分钟前
2分钟前
炜大的我的应助被科研通管家采纳,获得10
2分钟前
炜大的我的应助被科研通管家采纳,获得10
2分钟前
liuqingqing发布了新的文献求助10
2分钟前
专注寒蕾完成签到,获得积分10
2分钟前
3分钟前
11发布了新的文献求助10
3分钟前
3分钟前
liuqingqing发布了新的文献求助10
3分钟前
文静飞松完成签到,获得积分10
4分钟前
车厘子完成签到,获得积分10
4分钟前
含蓄的新柔完成签到,获得积分10
5分钟前
虫子完成签到,获得积分10
5分钟前
spinon完成签到,获得积分10
5分钟前
乐乐的应助被虚幻乌冬面采纳,获得10
5分钟前
5分钟前
香蕉觅云的应助被GIA采纳,获得10
5分钟前
披着羊皮的狼完成签到 ,获得积分0
5分钟前
沉默怡完成签到,获得积分10
6分钟前
岳鑫完成签到,获得积分10
6分钟前
6分钟前
科研通AI6.3的应助被紫熊采纳,获得10
6分钟前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 2000
Handbook of Sport Coaching Research 1000
Orthognathic Surgery - 2 Volume Set 500
高分子基功能界面水蒸发材料与应用研究 500
外场增强的水汽发电研究 500
基于结构调控的功能化水诱导发电材料与器件研究 500
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8195212
求助须知:如何正确求助?哪些是违规求助? 9580926
关于积分的说明 21873010
捐赠科研通 7795208
什么是DOI,文献DOI怎么找? 3437967
关于科研通互助平台的介绍 2561284
邀请新用户注册赠送积分活动 2484694